The United States Patent and Trademark Office’s (USPTO) Office of the Chief Economist released a report revealing that small companies and universities led the way in developing inventions to diagnose COVID-19, as evidenced by patent applications filed at the USPTO through April 2023.
The U.S. federal government helped spur this invention, with 10.7% of COVID-19 diagnostic public filings receiving support. The National Institutes of Health provided the most assistance (about 64%), while the National Science Foundation provided the second most, at 21.59%. Although COVID-19 diagnostic invention was highly concentrated in a few technologies, 8.6% of these inventions were also applicable to the treatment of COVID-19. Among 5,585 global COVID-19 diagnostic patent families found in this study, 47% have at least one filing at the China National Intellectual Property Administration (CNIPA), the most of any jurisdiction.
Many trademarks may include non-protectable elements, which describe the type of goods these marks are…
Mongolia stands out as a rapidly developing market, representing significant opportunities for both East Asian…
Sega Corporation, a well-known Japanese video game producer has entered in an agreement with a…
The Eurasian Patent Organization will be raising the fees for several services starting from February…
In 1995, the Eurasian Patent Convention (EAPC) was established to create a unified patent space,…